Hori M, Koretsune Y, Sato H, Kagiya T, Kitabatake A, Kamada T
First Department of Medicine, Osaka University School of Medicine, Japan.
Heart Vessels Suppl. 1991;6:11-7. doi: 10.1007/BF01752531.
Increased plasma catecholamines - in particular, excessive beta-adrenoceptor activation in chronic heart failure - may easily desensitize the beta-adrenoceptors as well as the postreceptor signal transductions. Since these detrimental changes in the failing heart could be reversible, administration of low-dose beta-blocker, which minimizes the negative inotropic effects, may be effective in attenuating the harmful effects of sympathetic nerve activation. Beta-adrenoceptor stimulation may also produce microtubule disruptions of the cell either through direct action or through an increase in heart rate. Treatment with beta-blockers could attenuate Ca overload by slowing the heart rate and may be useful as a protection from the structural disintegration of the cell. Thus, to clarify the underlying mechanisms of beta-blocker therapy for chronic heart failure, we have to consider not only to the functional aspects but also to the structural changes of the cells.
血浆儿茶酚胺增加——特别是在慢性心力衰竭中β-肾上腺素能受体过度激活——可能很容易使β-肾上腺素能受体以及受体后信号转导脱敏。由于衰竭心脏中的这些有害变化可能是可逆的,给予低剂量β受体阻滞剂(可将负性肌力作用降至最低)可能有效地减轻交感神经激活的有害影响。β-肾上腺素能受体刺激也可能通过直接作用或通过心率增加导致细胞微管破坏。用β受体阻滞剂治疗可通过减慢心率减轻钙超载,可能有助于防止细胞结构解体。因此,为了阐明β受体阻滞剂治疗慢性心力衰竭的潜在机制,我们不仅要考虑细胞的功能方面,还要考虑细胞的结构变化。